Role of Nitric Oxide Pathway in Placental Dysfunction Following Fetal Bypass

Annals of Thoracic Surgery

Volumn 84, Issue 3, 2007, Pages 917-925

  Lam, Christopher ^a   Baker, R Scott ^a,b   McNamara, Jerri ^a   Ferguson, Robert ^a   Lombardi, John ^a   Clark, Kenneth ^b   Eghtesady, Pirooz ^a,b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC GMP; NITRIC OXIDE; PHOSPHODIESTERASE V;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD FLOW; BLOOD SAMPLING; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; FEMALE; FETUS; FETUS SURGERY; GAS EXCHANGE; GESTATIONAL AGE; HEMODYNAMICS; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; METABOLITE; NONHUMAN; PLACENTA CIRCULATION; PLACENTA INSUFFICIENCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHEEP; STATISTICAL ANALYSIS; TREATMENT OUTCOME; UMBILICAL CORD BLOOD; VASCULAR RESISTANCE;

3',5'-CYCLIC-GMP PHOSPHODIESTERASE; ANIMALS; CARBON DIOXIDE; CARDIOPULMONARY BYPASS; CYCLIC GMP; FEMALE; FETUS; NITRATES; NITRIC OXIDE; NITRITES; OXYGEN; PLACENTA; PLACENTA DISEASES; POSTOPERATIVE COMPLICATIONS; PREGNANCY; SHEEP; SIGNAL TRANSDUCTION;

EID: 34548036476     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2007.04.057     Document Type: Article

References (33)

1. Hanley F.L. Fetal cardiac surgery. Adv Card Surg 5 (1994) 47-74
2. Park H.K., and Park Y.H. Fetal surgery for congenital heart disease. Yonsei Med J 42 (2001) 686-694
3. Allan L. Technique of fetal echocardiography. Pediatr Cardiol 25 (2004) 223-233
4. Champsaur G., Vedrinne C., Martinot S., et al. Flow-induced release of endothelium-derived relaxing factor during pulsatile bypass: experimental study in the fetal lamb. J Thorac Cardiovasc Surg 114 (1997) 738-745
5. Bradley S.M., Hanley F.L., Duncan B.W., et al. Fetal cardiac bypass alters regional blood flows, arterial blood gases, and hemodynamics in sheep. Am J Physiol 263 (1992) H919-H928
6. Myatt L., Eis A.L., Brockman D.E., Greer I.A., and Lyall F. Endothelial nitric oxide synthase in placental villous tissue from normal, pre-eclamptic and intrauterine growth restricted pregnancies. Hum Reprod 12 (1997) 167-172
7. Vedrinne C., Tronc F., Martinot S., et al. Better preservation of endothelial function and decreased activation of the fetal renin-angiotensin pathway with the use of pulsatile flow during experimental fetal bypass. J Thorac Cardiovasc Surg 120 (2000) 770-777
8. Champsaur G., Parisot P., Martinot S., et al. Pulsatility improves hemodynamics during fetal bypass. Experimental comparative study of pulsatile versus steady flow. Circulation 90 (1994) II47-II50
9. Vedrinne C., Tronc F., Martinot S., et al. Effects of various flow types on maternal hemodynamics during fetal bypass: is there nitric oxide release during pulsatile perfusion?. J Thorac Cardiovasc Surg 116 (1998) 432-439
10. Reddy V.M., McElhinney D.B., Rajasinghe H.A., et al. Role of the endothelium in placental dysfunction after fetal cardiac bypass. J Thorac Cardiovasc Surg 117 (1999) 343-351
11. Karteris E., Vatish M., Hillhouse E.W., and Grammatopoulos D.K. Preeclampsia is associated with impaired regulation of the placental nitric oxide-cyclic guanosine monophosphate pathway by corticotropin-releasing hormone (CRH) and CRH-related peptides. J Clin Endocrinol Metab 90 (2005) 3680-3687
12. Vatish M., Randeva H.S., and Grammatopoulos D.K. Hormonal regulation of placental nitric oxide and pathogenesis of pre-eclampsia. Trends Mol Med 12 (2006) 223-233
13. Palmer R.M., Ashton D.S., and Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 333 (1988) 664-666
14. Sessa W.C., Harrison J.K., Luthin D.R., Pollock J.S., and Lynch K.R. Genomic analysis and expression patterns reveal distinct genes for endothelial and brain nitric oxide synthase. Hypertension 21 (1993) 934-938
15. Ignarro L.J., Ross G., and Tillisch J. Pharmacology of endothelium-derived nitric oxide and nitrovasodilators. West J Med 154 (1991) 51-62
16. Moncada S., Palmer R.M., and Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43 (1991) 109-142
17. Lubbers W.C., Baker R.S., Sedgwick J.A., et al. Vacuum-assisted venous drainage during fetal cardiopulmonary bypass. ASAIO J 51 (2005) 644-648
18. Eghtesady P., Sedgwick J.A., Schenbeck J.L., et al. Maternal-fetal interactions in fetal cardiac surgery. Ann Thorac Surg 81 (2006) 249-256
19. Neishi Y., Mochizuki S., Miyasaka T., et al. Evaluation of bioavailability of nitric oxide in coronary circulation by direct measurement of plasma nitric oxide concentration. Proc Natl Acad Sci USA 102 (2005) 11456-11461
20. Lyons J.M., Duffy J.Y., Wagner C.J., and Pearl J.M. Sildenafil citrate alleviates pulmonary hypertension after hypoxia and reoxygenation with cardiopulmonary bypass. J Am Coll Surg 199 (2004) 607-614
21. Fenton K.N., Heinemann M.K., Hickey P.R., Klautz R.J., Liddicoat J.R., and Hanley F.L. Inhibition of the fetal stress response improves cardiac output and gas exchange after fetal cardiac bypass. J Thorac Cardiovasc Surg 107 (1994) 1416-1422
22. Lombardi J., Sedgwick J., Schenbeck J., et al. Cardiopulmonary bypass in the immature fetus through novel use of a mini-centrifugal pump. Perfusion 21 (2006) 185-191
23. Ng W.H., Moochhala S., Yeo T.T., Ong P.L., and Ng P.Y. Nitric oxide and subarachnoid hemorrhage: elevated level in cerebrospinal fluid and their implications. Neurosurgery 49 (2001) 622-627
24. Chen L., Salafranca M.N., and Mehta J.L. Cyclooxygenase inhibition decreases nitric oxide synthase activity in human platelets. Am J Physiol 273 (1997) H1854-H1859
25. Coppage K.H., Sun X., Baker R.S., and Clark K.E. Expression of phosphodiesterase 5 in maternal and fetal sheep. Am J Obstet Gynecol 193 (2005) 1005-1010
26. Kim P., Lorenz R.R., Sundt Jr. T.M., and Vanhoutte P.M. Release of endothelium-derived relaxing factor after subarachnoid hemorrhage. J Neurosurg 70 (1989) 108-114
27. Wennmalm A., Benthin G., and Petersson A.S. Dependence of the metabolism of nitric oxide (NO) in healthy human whole blood on the oxygenation of its red cell haemoglobin. Br J Pharmacol 106 (1992) 507-508
28. Dinerman J.L., Lowenstein C.J., and Snyder S.H. Molecular mechanisms of nitric oxide regulation. Potential relevance to cardiovascular disease. Circ Res 73 (1993) 217-222
29. McMullan D.M., Bekker J.M., Parry A.J., et al. Alterations in endogenous nitric oxide production after cardiopulmonary bypass in lambs with normal and increased pulmonary blood flow. Circulation 102 19 Suppl 3 (2000) III172-III178
30. Krukier I.I. Production of NO and oxidative destruction of proteins in the placenta during normal pregnancy and placental insufficiency. Bull Exp Biol Med 136 (2003) 369-371
31. Zhang Q., Moalem J., Tse J., Scholz P.M., and Weiss H.R. Effects of natriuretic peptides on ventricular myocyte contraction and role of cyclic GMP signaling. Eur J Pharmacol 510 (2005) 209-215
32. Rybalkin S.D., Rybalkina I.G., Shimizu-Albergine M., Tang X.B., and Beavo J.A. PDE-5 is converted to an activated state upon cGMP binding to the GAF A domain. Embo J 22 (2003) 469-478
33. Lin C.-S., Chow S., Lau A., Tu R., and Lue T.F. Identification and regulation of human PDE-5A gene promoter. Biochem Biophys Res Commun 280 (2001) 684-692